22
Participants
Start Date
December 5, 2020
Primary Completion Date
November 30, 2023
Study Completion Date
November 30, 2023
Doppler Ultrasound
Power Doppler measurements will be made
SIEMENS S3000 and Verasonics Vantage 256
Vantage 256 used for power Doppler ultrasound, manufactured by Verasonics
Standard-of-care Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) tyrosine kinase inhibitor (TKI) plus immune checkpoint inhibitor (ICI)
Standard-of-care Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) tyrosine kinase inhibitor (TKI) plus immune checkpoint inhibitor (ICI).
Standard-of-care non-immune checkpoint inhibitor (ICI) such as single-agent VEGFR2 TKI
Standard-of-care non-immune checkpoint inhibitor (ICI) such as single-agent VEGFR2 TKI
Stanford University School of Medicine, Stanford
National Institutes of Health (NIH)
NIH
Stanford University
OTHER